Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report

Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report

Abstract Background Nivolumab is a monoclonal antibody against programmed death 1 and has become a standard treatment of advanced melanoma because of its durable response and survival benefits. In this report, we present a case of severe intestinal perforation after nivolumab immunotherapy for malig...

Full description

Saved in:
Bibliographic Details
Main Authors: Koji Yasuda, Toshiaki Tanaka, Soichiro Ishihara, Kensuke Otani, Takeshi Nishikawa, Tomomichi Kiyomatsu, Kazushige Kawai, Keisuke Hata, Hiroaki Nozawa, Yuri Masui, Yukako Shintani, Toshiaki Watanabe
Format: Article
Language:English
Published: Japan Surgical Society 2017-08-01
Series:Surgical Case Reports
Subjects:
Nivolumab
Intestinal perforation
Malignant melanoma
Online Access:http://link.springer.com/article/10.1186/s40792-017-0370-7
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

http://link.springer.com/article/10.1186/s40792-017-0370-7

Similar Items